Under this agreement NorthX will manufacture Lipum´s lead asset,
Janet Hoogstraate, CEO of NorthX Biologics added “We are excited to be working on
About
NorthX Biologics, a leading
© Modular Finance, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.5 SEK | -1.52% | -0.76% | -0.31% |
May. 06 | Lipum Obtains SEK20 Million Loan from Flerie Invest | MT |
Apr. 02 | Lipum Strengthens Its Protection of the Drug Candidate Sol-116 Through A Patent Application for Inflammation-Driven Cancer | CI |
Under this agreement NorthX will manufacture Lipum´s lead asset,
Janet Hoogstraate, CEO of NorthX Biologics added “We are excited to be working on
About
NorthX Biologics, a leading
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
-0.31% | 13.08M | |
-2.32% | 92.59B | |
+3.68% | 41.43B | |
-11.30% | 33.49B | |
-20.21% | 14.62B | |
-9.30% | 12.77B | |
-11.34% | 11.58B | |
-43.53% | 11.35B | |
+3.75% | 8.97B | |
-6.32% | 8.3B |